Raymond James & Associates’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.49M Buy
400,211
+150,948
+61% +$3.15M 0.01% 1316
2024
Q2
$5.06M Buy
249,263
+30,856
+14% +$623K ﹤0.01% 1562
2024
Q1
$4.48M Buy
218,407
+49,317
+29% +$1.01M ﹤0.01% 1670
2023
Q4
$3.51M Buy
169,090
+130,450
+338% +$2.57M ﹤0.01% 1756
2023
Q3
$749K Buy
38,640
+4,170
+12% +$83K ﹤0.01% 2648
2023
Q2
$699K Sell
34,470
-2,703
-7% -$55.2K ﹤0.01% 2701
2023
Q1
$767K Buy
37,173
+2,380
+7% +$48.6K ﹤0.01% 2634
2022
Q4
$692K Sell
34,793
-549
-2% -$10.9K ﹤0.01% 2656
2022
Q3
$690K Buy
35,342
+144
+0.4% +$3K ﹤0.01% 2628
2022
Q2
$732K Buy
35,198
+5,948
+20% +$127K ﹤0.01% 2656
2022
Q1
$665K Hold
29,250
﹤0.01% 2883
2021
Q4
$727K Hold
29,250
﹤0.01% 2833
2021
Q3
$731K Buy
+29,250
New +$743K ﹤0.01% 2785

Other funds holding IBDW

Raymond James & Associates's IBDW Position: Q3 2024 in Review

Raymond James & Associates increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 61% in Q3 2024, buying an estimated $3.15M and bringing the position to 400,211 shares worth $8.49M. The position accounts for 0.01% of the portfolio, ranked #1316.

Raymond James & Associates first reported a position in IBDW in Q3 2021 and has held it in 13 quarters since. 153 funds tracked by Wall St. Rank hold IBDW as of Q3 2024.

  • Raymond James & Associates held 400,211 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $8.49M as of Q3 2024.
  • Raymond James & Associates bought 150,948 iShares iBonds Dec 2031 Term Corporate ETF shares in Q3 2024, an estimated $3.15M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1316 holding.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q3 2021 and has held it in 13 quarters since.
  • 153 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.